Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 751 results found. Search for [ drug quality ]

Results 1 to 21 of 751
BusinessToday.In
May 11, 2021
The three Indian drugmakers - Cipla Ltd, Lupin Ltd, and Sun Pharma will collaborate with Lilly to manufacture and distribute Baricitinib in India. The drug is approved by the Central Drugs Standard Control Organization (CDSCO) for restricted emergency use in India


Joe C Mathew
May 10, 2021
Lilly said the company is also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses. These voluntary licensing agreements will ensure high quality manufacturing and accessibility of Baricitinib


BusinessToday.In
May 10, 2021
Baricitinib was issued a restricted emergency use approval by the health ministry's CDSCO for the use in combination with Remdesivir for treatment of Covid-19


Joe C Mathew
April 14, 2021
Addressing a virtual press briefing on April 13, Dmitriev said its vaccine partnership covers 20 producers in 10 countries including Korea, China and India


Associated Press
April 1, 2021
A vaccine ingredient made by Emergent BioSolutions -- one of about 10 companies that Johnson and Johnson is using to speed up manufacturing of its recently approved vaccine -- did not meet quality standards, J&J said on Wednesday


PB Jayakumar
March 31, 2021
Hemmo is one of the few pure-play synthetic peptide API manufacturers in the global marketplace. It has R&D capabilities and a world-class GMP manufacturing facility at Thurbhe in Navi Mumbai


BusinessToday.In
March 30, 2021
Biocon share price rose as much as 2.71 per cent to hit intraday high of Rs 406 on the BSE after the biopharma company signed pact with Libbs Farmaceutica to launch generic formulations in Brazil


BusinessToday.In
March 24, 2021
Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery


Joe C Mathew
March 11, 2021
Hindustan Syringes & Medical Devices says it has had to rehire 1,000 people to replace those who had left it during onset of Covid1-19. From 500 million pieces per annum capacity of 0.5 ml AD Syringes in June 2020, it is today producing 800 million per annum


BusinessToday.In
March 4, 2021
Indian Institute of Technology-Bombay has secured an overall ranking of 49 followed by IIT-Delhi at 54 and IIT-Madras at 94


Associated Press
March 3, 2021
White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously


PB Jayakumar
February 26, 2021
SS Innovations is planning to make 100 units this year of the multi arm novel 'Mantra' Surgical Robotic System indigenously developed over the last three years. Plans are to make and sell over 1,000 units within the next five years


BusinessToday.In
February 24, 2021
Balkrishna said that the medicines introduced during the press conference have been validated through in-depth in-vitro and in-vivo biological and chemical studies, along with randomised clinical trials


Rashi Bisaria
New Delhi, February 24, 2021
Patanjali's Coronil not to be sold in Maharashtra without 'proper certifications' The sale of Patanjali's Coronil tablets will not be permitted without \"proper certifications\" in Maharashtra, said the state's Home Minister Anil Deshmukh on Tuesday. Deshmukh's statements come a day after the Indian Medical Association (IMA) expressed shock over Patanjali's claims of getting WHO certification for Coronil tablets, which it says is an evidence-based medicine to fight COVID-19. Uttarakhand f...


PTI
February 22, 2021
In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent


Joe C Mathew
February 22, 2021
While the prices of four categories of medical devices - coronary stents, drug-eluting stents, condoms, and intrauterine devices - are already fixed by NPPA, the prices of the rest are fixed by the manufacturers themselves


BusinessToday.In
February 22, 2021
In a tweet, the WHO South-East Asia wrote, 'WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment of COVID-19'


BusinessToday.In
February 19, 2021
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


Avneet Kaur
February 19, 2021
Most industry experts expect a further fall in the gold price. With yields rising and technical levels under fire, the fall in gold prices may continue, they say. Some even expect the prices to fall to Rs 43,000 levels


Nevin John
February 19, 2021
In device manufacturing, medical and diagnostics will be another focus area for the Tata Group chairman


PAGES 1 OF 38  12345